Drug intelligence / Profile preview

miR-148a-5p mimic

Development stage
Preclinical
Modality
RNA Therapeutics → Nucleic Acid Therapeutics
Administration
Intravenous, Subcutaneous, Intratumoral, Intraperitoneal, Parenteral
01

Overview

miR-148a-5p mimic is a synthetic, double-stranded RNA oligonucleotide designed to simulate the functional activity of the endogenous microRNA miR-148a-5p. In the context of multiple myeloma (MM) research, miR-148a-5p has been identified as significantly overexpressed in patients compared to healthy controls. While its sister strand, miR-148a-3p, has been shown to promote cell proliferation and target tumor suppressor genes like CCDC6, experimental transfection of miR-148a-5p mimics in MM cell lines (such as KMS28BM and KMS27) has not demonstrated significant alterations in cell proliferation. The mimic functions by incorporating into the RNA-induced silencing complex (RISC) to mediate post-transcriptional gene silencing of target mRNAs, serving as a critical tool for investigating the differential roles of miRNA arms in plasma cell dyscrasias.

Other names
microRNA-148a-5p mimicmicroRNA148a-5p mimicmicroRNA 148a-5p mimichsa-miR-148a-5p mimichsa-miR148a-5p mimichsa-miR 148a-5p mimicmiR-148a-5pmiR148a-5pmiR 148a-5p
02

Targets

TLR7/8 (Toll-like receptor 7 and Toll-like receptor 8)Messenger RNAs bearing miR-148a-5p seed-complementary sitesAGO2 (Argonaute RISC catalytic component 2)

Beyond the preview

Go deeper on miR-148a-5p mimic.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on miR-148a-5p mimic.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call